17th November 2022
22nd March 2022
Safety and Efficacy Results from Phase 1 (PEARL-1) Cohort 2 Evaluating KB301, an Investigational COL3A1 Gene Delivery Treatment, for the Treatment of Aesthetic Conditions
19th November 2021
Preclinical Evaluation of KB303, An Innovative And Minimally Invasive HSV-1-Based Therapy to Improve Skin Elasticity
27th May 2021
First-in-Human Safety and Mechanism of Action (MOA) Analyses of Repeatedly Dosed KB301 for In Vivo Gene Delivery for Directed Human Type III Collagen (COL3) Expression in Aesthetics
26th May 2021